AGM/EGMJun 24, 2026, 06:07 AM
Takeda Shareholders Approve JPY 100 Dividend, Elect Directors
AI Summary
Takeda Pharmaceutical Company Limited announced the resolutions passed at its 150th Annual General Meeting of Shareholders. Key approvals included a year-end dividend of JPY 100 per share and the election of new and re-elected directors for both the Board and the Audit and Supervisory Committee. Shareholders also approved bonuses for non-Audit and Supervisory Committee Directors up to JPY 260 million.
Key Highlights
- Shareholders approved a year-end dividend of JPY 100 per share.
- Eight Directors who are not Audit and Supervisory Committee Members were elected, including Julie Kim and Paul Stoffels.
- Three Directors who are Audit and Supervisory Committee Members were elected, including Bruce Broussard and Koichiro Kimura.
- One Substitute Director who is an Audit and Supervisory Committee Member, Paul Stoffels, was elected.
- Bonuses totaling up to JPY 260 million were approved for two non-Audit and Supervisory Committee Directors.
Price Impact
More from TAK